Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aerovate Therapeutics | AVTE | Nov 27, 2024 | 2.64 | -1.49 |
AeroVironment | AVAV | Nov 27, 2024 | 190.87 | -2.87 |
AerSale | ASLE | Nov 27, 2024 | 6.25 | -0.48 |
AES | AES | Nov 27, 2024 | 12.99 | +3.26 |
Aetherium Acquisition A | GMFI | Nov 27, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Nov 27, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Nov 27, 2024 | 0.40 | +0.84 |
Aeva Technologies | AEVA | Nov 27, 2024 | 4.75 | +4.86 |
AEye A | LIDR | Nov 27, 2024 | 1.07 | 0.00 |
Affiliated Managers Group | AMG | Nov 27, 2024 | 188.46 | -0.42 |
Affimed N.V. | AFMD | Nov 27, 2024 | 2.84 | -1.05 |
Affinity Bancshares | AFBI | Nov 27, 2024 | 21.50 | -0.56 |
Affirm A | AFRM | Nov 27, 2024 | 68.37 | +3.17 |
Aflac | AFL | Nov 27, 2024 | 114.10 | +0.07 |
Africa Index ETF Market Vectors | AFK | Nov 27, 2024 | 16.05 | -0.06 |
Afya A | AFYA | Nov 27, 2024 | 16.73 | -1.88 |
Ag Mortgage Investment Trust | MITT | Nov 27, 2024 | 6.81 | +1.34 |
AG Mortgage Investment Trust A Pref | MITT-A | Nov 27, 2024 | 22.45 | -0.09 |
AG Mortgage Investment Trust B Pref | MITT-B | Nov 27, 2024 | 22.45 | +0.27 |
AG Mortgage Investment Trust C Pref | MITT-C | Nov 27, 2024 | 25.44 | +0.33 |
Agape ATP | ATPC | Nov 27, 2024 | 1.55 | -0.64 |
AGCO | AGCO | Nov 27, 2024 | 101.46 | +2.08 |
AgEagle Aerial Systems | UAVS | Nov 27, 2024 | 6.12 | +13.54 |
Agency Bond Ishares | AGZ | Nov 27, 2024 | 108.90 | +0.13 |
Agenus | AGEN | Nov 27, 2024 | 3.49 | +3.25 |
Aggregate Bond Ishares | AGG | Nov 27, 2024 | 98.81 | +0.27 |
Agilent Technologies | A | Nov 27, 2024 | 138.14 | +2.81 |
Agilon Health | AGL | Nov 27, 2024 | 2.11 | +2.93 |
Agilysys | AGYS | Nov 27, 2024 | 133.89 | -2.78 |
Agios Pharmaceuticals | AGIO | Nov 27, 2024 | 58.66 | -0.74 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.